Tocilizumab Injectable Product
V4.0, 20220410
Phase 2 small_molecule active
Quick answer
Tocilizumab Injectable Product for Myasthenia Gravis, Generalized is a Phase 2 program (small_molecule) at Tang-Du Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tang-Du Hospital
- Indication
- Myasthenia Gravis, Generalized
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active